Quotazioni in diretta
| Data | Ora | Fonte | Titolo |
|---|---|---|---|
| 22/5/2024 | 18:06 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 14/5/2024 | 22:10 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 17/1/2024 | 12:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 11/1/2024 | 22:10 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 16/11/2023 | 22:10 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 09/11/2023 | 22:10 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 06/11/2023 | 13:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 05/9/2023 | 22:10 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 12/7/2023 | 22:10 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 31/5/2023 | 22:44 | PRNUS | Seal Rock Therapeutics Announces Out-Licensing Agreement.. |
| Apertura: 4,33 | Min: 4,285 | Max: 4,49 |
| Chiusura: 4,10 |
|
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni |
|
ADVFN Network
|
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
